Document Detail

Revival of the use of botulinum toxin: application in dermatology.
MedLine Citation:
PMID:  10894957     Owner:  NLM     Status:  MEDLINE    
Botulinum toxins (BTXs) comprise a family of neurotoxins designated as types A-G, which are produced by the anerobic bacterium Clostridium botulinum. BTX-A blocks the cholinergic transmission resulting in flaccid paralysis and autonomous nerve dysfunction. It has become a powerful therapeutic tool in a variety of conditions over the last decades. Primarily used in the treatment of strabismus, blepharospasm and hemifacial spasms, BTX has only recently been recognized in dermatology. The use of BTX in dermatology includes the treatment of focal hyperhidrosis, hyperfunctional facial lines as well as paralysis of the anal sphincter in the therapy of anal fissures. The mechanism of action is described and the current literature is reviewed.
R Böni; O P Kreyden; G Burg
Related Documents :
9324087 - Chronic relapsing brachial plexus neuropathy with persistent conduction block.
7959467 - The immunocytochemical demonstration of a relative lack of nerve fibres in the atrioven...
7594987 - Angioleiomyomas of the hand. a report of 14 cases.
16076497 - Salivary gland choristoma of the middle ear in an infant: a case report.
8268107 - Gastrointestinal hemorrhage due to splenic artery aneurysm pancreatic duct fistula in c...
9973707 - Fibrous dysplasia of the jaw bone: a review of 15 new cases and two cases of recurrence...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Dermatology (Basel, Switzerland)     Volume:  200     ISSN:  1018-8665     ISO Abbreviation:  Dermatology (Basel)     Publication Date:  2000  
Date Detail:
Created Date:  2000-08-23     Completed Date:  2000-08-23     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  9203244     Medline TA:  Dermatology     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  287-91     Citation Subset:  IM    
Copyright Information:
Copyright 2000 S. Karger AG, Basel
Department of Dermatology, University Hospital, Zürich, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Botulinum Toxins / therapeutic use*
Skin / drug effects,  pathology
Skin Diseases / drug therapy*
Reg. No./Substance:
0/Botulinum Toxins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Genomic organization of the human ubiquitin-conjugating enzyme gene, UBE2L6 on chromosome 11q12.
Next Document:  Patient compliance and disease management in the treatment of psoriasis in the Netherlands.